Ontology highlight
ABSTRACT: Background
Neurobiological research frequently implicates inflammatory and neurogenic components with core aspects of bipolar disorder. Even in periods of symptom remission (euthymia), individuals with bipolar disorder experience cognitive impairments, which are increasingly being proposed as an outcome for interventions; identifying biomarkers associated with cognitive impairment in people with bipolar disorder could advance progress in this therapeutic field through identifying biological treatment targets.Aims
We aimed to identify proteomic biomarker correlates of cognitive impairment in individuals with euthymic bipolar disorder.Method
Forty-four adults with a bipolar disorder diagnosis in euthymia underwent a battery of cognitive assessments and provided blood
SUBMITTER: Strawbridge R
PROVIDER: S-EPMC8281256 | biostudies-literature | 2021 Jul
REPOSITORIES: biostudies-literature